Please login to the form below

Not currently logged in

Novo Nordisk launches new US insulin campaign

US IndyCar driver, diabetic and FlexPen user Charlie Kimball fronts activities


Novo Nordisk has launched a campaign featuring IndyCar Series driver Charlie Kimball.

Agencies supporting the campaign include Tip Nunn, Chip Ganassi Racing and New York-based Marina Maher Communications, whose client case studies include Merck & Co and Pfizer. 

Diagnosed with diabetes during a routine visit to a GP while racing in Europe in 2007, Kimball is the first licensed driver with diabetes to race at the highest level of the series.

The campaign features a website hosting a competition inviting entrants to build a 'pit crew' by enrolling two friends by email and be in with a chance of winning a VIP trip to the 2013 IndyCar finale and a Twitter feed. Campaign information booths will also be displayed at US racing venues.

A keen advocate of the notion that good management of diabetes is a team effort, Kimball says that it was working as a team that enables him to stay healthy on the track.

Kimball, who has a continuous blood sugar monitor said: ”It takes an entire crew to help me manage both my car and my diabetes, so we can compete at the highest levels”. “This programme is a great way for people to show support, especially for friends and family affected by diabetes, and encourage them to share my story.”

25th April 2013

From: Marketing



Featured jobs

Subscribe to our email news alerts


Add my company
Grace Communications

Grace Communications is a creative agency specialising in healthcare communication and understanding people's personality types....

Latest intelligence

The rise of real-world evidence
Demonstrating efficacy and value requires more than clinical trial data...
Digital health
The untapped potential to transform healthcare...
When is it time to rebrand?